Pulmonary function tests in interstitial lung disease: what role do they have? (Q34490580)

2 August 2017

1 reference

title

Pulmonary function tests in interstitial lung disease: what role do they have? (English)

1 reference

interstitial lung disease

2 August 2017

1 reference

Alhamad EH

1

1 reference

PubMed ID

11787661

2 August 2017

Lynch JP 3rd

series ordinal

2

1 reference

PubMed ID

11787661

2 August 2017

Martinez FJ

series ordinal

3

1 reference

2 August 2017

1 December 2001

1 reference

Clinics in Chest Medicine

2 August 2017

1 reference

2 August 2017

22

1 reference

2 August 2017

4

1 reference

2 August 2017

715-50, ix

1 reference

Lymphangiomyomatosis: CT, chest radiographic, and functional correlations

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Chronic hypersensitivity pneumonitis: high-resolution CT and radiographic features in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Determinants of susceptibility to cigarette smoke. Potential roles for neuroendocrine cells and neuropeptides in airway inflammation, airway wall remodeling, and chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Summer-type hypersensitivity pneumonitis: comparison of high-resolution CT and plain radiographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Statement on Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary involvement in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airway function in stage I and stage II pulmonary sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Exercise testing in the physiologic assessment of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical and physiologic features of some types of pulmonary diseases with impairment of alveolar-capillary diffusion; the syndrome of "alveolar-capillary block"

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Serial pulmonary function tests in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Migratory organizing pneumonitis "primed" by radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Survival in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Asymptomatic cavitary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Small airways in progressive systemic sclerosis (PSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Factors limiting exercise performance in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung transplantation for lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung mechanics and gas exchange during exercise in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary sarcoidosis: evaluation with high-resolution CT

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary histiocytosis X: evaluation with high-resolution CT

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary Langerhans'-Cell Histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary mechanics in lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Natural History and Treated Course of Usual and Desquamative Interstitial Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Structure and function in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary involvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Comprehensive Evaluation of 35 Patients With Lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Rapidly progressive bronchiolitis obliterans with organizing pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis. Pathologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Use of an exponential function for elastic recoil

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Sarcoidosis: course and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function follow-up to 120 patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Long-term physiologic outcome after acute farmer's lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Hypersensitivity pneumonitis in peat moss processing plant workers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans with organising pneumonia: outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function in patients receiving long-term low-dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The epidemiology of interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung function in rheumatoid arthritis. A clinic survey

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Inspiratory muscle force in normal subjects and patients with interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cryptogenic fibrosing alveolitis with preserved lung volumes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airway function in sarcoidosis: smokers versus nonsmokers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Long-term study of pulmonary sarcoidosis. The effect of steroid therapy as evaluated by pulmonary function studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Normal Chest Roentgenograms in Chronic Diffuse Infiltrative Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans organizing pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Long-term outcome of pulmonary function in farmer's lung: a 14 year follow-up with matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Long-term risk of emphysema in patients with farmer's lung and matched control farmers.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Severe Pulmonary Hypertension in Histiocytosis X

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function tests, serum angiotensin-converting enzyme levels, and clinical findings as prognostic indicators in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The role of pulmonary function testing in pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary Dysfunction in Rheumatoid Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Diffuse Fibrotic Lung Disease: A Correlative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Interstitial lung disease in recent onset rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary mechanics in fibrosing alveolitis: the effects of lung shrinkage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bulk elastic properties of excised lungs and the effect of a transpulmonary pressure gradient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung function and the response to exercise in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary alveolar proteinosis: clinical features and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Inspiratory muscle strength and respiratory drive in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Alveolar size as a determinant of pulmonary distensibility in mammalian lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pathophysiology of activity limitation in patients with interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Farmer's lung. A clinical, radiographic, functional, and serological correlation of acute and chronic stages

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Oxygen improves maximal exercise performance in interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airflow limitation in sarcoidosis--a study of pulmonary function in 107 patients with newly diagnosed disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Structural features of interstitial lung disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchial reactivity and airflow obstruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolar disease in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary manifestations associated with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary sarcoidosis: roentgenographic, functional, and pathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung function in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

A longitudinal study of pulmonary function in Danish patients with systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lymphangioleiomyomatosis: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Volume adjustment of mechanics and diffusion in interstitial lung disease. Lack of clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Interlaboratory and intralaboratory variability in pulmonary function testing. A 13-year study using a normal biologic control

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pleuropulmonary manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Obliterative bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Importance of the lower respiratory tract in oxygen transfer. Exercise testing in patients with interstitial and destructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Evaluation of lung elastic recoil by exponential curve analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Mortality due to farmer's lung in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung Involvement in Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Small airways dysfunction in systemic sclerosis. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Diagnostic accuracy of transbronchial biopsy in acute farmer's lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Respiratory function in systemic lupus erythematosus, scleroderma, and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Farmer's lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airway obstruction in bronchial sarcoidosis: outcome with treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary lymphangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin-section CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airway function in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Chronic pulmonary sarcoidosis: relationship between lung lavage cell counts, chest radiograph, and results of standard lung function tests

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

An 8-year follow-up study of pulmonary function in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchial hyperreactivity in fresh stage I sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Exercise testing in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolar narrowing and occlusion in sarcoidosis--correlation of pathology with physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung function in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

A radiographic classification for sarcoidosis: physiologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Mechanical properties of lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Skeletal muscle involvement in progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function in stage I and II pulmonary sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Diseases of the bronchioles: CT and histopathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung fibrosis in hypersensitivity pneumonitis. Association with CD4+ but not CD8+ cell dominant alveolitis and insidious onset

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

NSIP, UIP, and the ABCs of idiopathic interstitial pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

1 reference

7 January 2021

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary lymphangioleiomyomatosis in Korea

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Sarcoidosis patients have bronchial hyperreactivity and signs of mast cell activation in their bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic bronchiolitis obliterans with organizing pneumonia presenting with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

High resolution computed tomography in systemic sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary involvement in progressive systemic sclerosis: a multidisciplinary approach

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Prediction of interstitial lung involvement in rheumatoid arthritis. The value of clinical data, chest roentgenogram, lung function, and serologic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Interstitial rheumatoid lung disease. A reassessment and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airways disease in rheumatoid arthritis patients. One element of a general exocrine dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Utility of a provocation test for diagnosis of chronic pigeon Breeder's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Assessment of diffuse infiltrative lung disease: comparison of conventional CT and high-resolution CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Subacute and chronic bird breeder hypersensitivity pneumonitis: sequential evaluation with CT and correlation with lung function tests and bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary Function in Diffuse Sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The Pulmonary Pathology of Farmer's Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Diagnostic and management strategies for diffuse interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

A prospective, multicenter study of a pneumonia practice guideline.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

PULMONARY FUNCTION IN SCLERODERMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

THE PATHOPHYSIOLOGY OF SCLERODERMA INVOLVING THE HEART AND RESPIRATORY SYSTEM

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

AN ANALYSIS OF PRESSURE-VOLUME CHARACTERISTICS OF THE LUNGS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Small airways function in nonsmokers with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Membrane diffusing capacity and pulmonary capillary blood volume in pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Functional evaluation in stage I pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Serial pulmonary function in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The diagnosis of hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Determinants of survival in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary sarcoidosis and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary lymphangiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The prognosis of cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Isolated diffusing capacity reduction in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function in patients with endobronchial sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Decreased pulmonary distensibility in fibrosing alveolitis and its relation to decreased lung volume

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Methotrexate in sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

1 reference

7 January 2021

Prognosis of cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Bronchiolitis obliterans-organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary Langerhans'-cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Airway obstruction and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Studies on respiratory mechanics and the work of breathing in pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cigarette smoking and pulmonary diffusion defects in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

PULMONARY FUNCTION STUDIES IN PATIENTS WITH FARMER'S LUNG.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The Significance of Lung Function Changes in Asbestosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

AN EARLY PULMONARY PHYSIOLOGIC ABNORMALITY IN PROGRESSIVE SYSTEMIC SCLEROSIS (DIFFUSE SCLERODERMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

A Clinical Interpretation of Bilateral Hilar Adenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Use of pulmonary function tests in the management of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Hypersensitivity pneumonitis from Pezizia domiciliana. A case of El Niño lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Clinical features of BOOP in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Occupational hypersensitivity pneumonitis in Japan: data on a nationwide epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

The pulmonary pathologic manifestations of the CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970062-9

7 January 2021

10.1016/S0272-5231(05)70062-9

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11787661